Pediatric Respiratory Infections Back to Pre-Pandemic Patterns
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
Read MoreChildren’s Hospital Los Angeles joined a trial to investigate nula-cel, a gene-editing therapy designed to correct the sickle cell disease genetic mutation.
Read MoreAstraZeneca’s triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
Read MoreNew UNICEF/WHO data show that high drop-out rates for measles vaccines continue to fuel disease outbreaks.
Read MoreA two-year-old Indiana child is the first in the United States to be diagnosed with Rajab interstitial lung disease with brain calcifications, a rare genetic disease with only 10 known cases worldwide.
Read MoreA 10-year analysis of emergency department data shows one sport poses a greater risk of severe injury to youth athletes.
Read MoreResearchers linked loss-of-function variants in the TMEM63B gene to a novel disorder causing interstitial lung disease in some pediatric patients.
Read MoreUnderlying chronic conditions and hospital transfers are major indicators of severe disease in pediatric patients with respiratory tract infections.
Read MoreData on 9,000 children with septic shock shows no difference in kidney outcomes between two common types of IV fluids used for emergency resuscitation.
Read MoreResearch involving more than 30,000 children suggests no link between household cats and asthma severity or lung function.
Read MoreA 10-year study in sub-Saharan Africa revealed that a higher dose of the oral medication Hydroxyurea improved survival and growth outcomes in children with sickle cell anemia.
Read MoreChildren with long COVID report higher levels of fatigue and sleep disturbance than those with cancer or autism.
Read MoreHigh ozone pollution levels may counteract the respiratory healthcare improvements gained through vigorous physical activity in pediatric populations.
Read MorePediatric pulmonary rehab programs enhance exercise capacity, strength, and quality of life even when lung function measurements remain stable.
Read MoreHigh consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
Read MoreNonasthmatic eosinophilic bronchitis remains a frequently overlooked cause of chronic cough in pediatric patients.
Read MoreNew studies suggest that airway and breathing failures are the primary causes of death in childhood food anaphylaxis, requiring a shift in emergency management protocols.
Read MoreThe 2026 “State of the Air” report reveals that 82% of Californians live in areas with failing air quality grades for ozone or particle pollution.
Read MoreThe American Lung Association’s “State of the Air” report indicates that 33.5 million children live in communities with failing grades for ozone or particle pollution.
Read MoreA study of emergency department patients found that the SaFETy score can identify the risk of firearm-related incidents within one year.
Read MoreLeading healthcare groups challenge the repeal of updated limits on toxic pollutants from power plants, citing risks to respiratory health and child development.
Read MoreThe European Commission authorized the EURneffy 1 mg nasal spray for pediatric patients who weigh between 15 and 30 kg and are at risk of severe allergic reactions.
Read MoreThe updated label for the Neffy 1 mg dose allows children weighing at least 33 pounds to access the needle-free treatment regardless of age.
Read MoreReducing dampness through insulation and ventilation improvements can lead to measurable reductions in asthma treatments, particularly for pediatric populations.
Read More